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At On Target Laboratories, based in Purdue’s Research 
Park, under direction of Professor Phillip Low, a new 
technique in cancer surgery is being developed which 
has the potential to innovate current clinical standards 
by improving surgery results and lower health-care 
costs. This technique is innovative in that it will provide 
surgeons an illuminated road map during surgery using 
the “Trojan Horse” method. This method specifically 
targets cancer cells and differentiates them from 
healthy cells. After cancer cells are targeted, they are 
illuminated by near-infrared (NIR) fluorescence. NIR 
is used because of its increased photon transportation. 
Photons can travel up to centimeters through blood and 
tissue, improving the identification of targets below 
the surface. This research consists of developing small 
molecules consisting of a near-infrared dye, linker, 
and cancer targeting ligand. Various ligands, including 
folate, are being developed to target different cancers 
such as ovarian, breast, colon, pancreatic, and prostate 
cancer. After the targeted NIR imaging agents have 
been developed, their photo-physical properties such 
as excitation, emission, quantum yield, and stability 
are analyzed using ultraviolet-visible spectroscopy 
and fluorometery. After assessing the molecules, their 
binding and specificity for cancer cells are evaluated both 
in vitro and in vivo using cultured cancer cells and tumor 
xenograft mice models. The targeted probes (consisting 
of the ligand linked to the NIR dye) are accumulated in 
the tumors with no uptake in other tissues leading to very 
high signal-to-noise ratio. The next steps in this research 
project involve further study in other animal models 
to evaluate any possible side effects and then progress 
into human clinical trials. Advancements in this image-
guided technique could improve the ability of surgeons 
to diagnose cancer and surgically remove more cancer 
tissue than would have been otherwise possible. There 
are other potential uses for this technology including in 
inflammation related diseases. 
Researcher advisor Sumith A. Kularatne says, “40% of 
patients undergoing cancer surgery each year in the U.S. 
have a recurrence of the disease within 5 years. Therefore, 
an unmet medical demand exists to develop techniques 
to remove primary malignant mass with entirely negative 
margins and remove all lymph nodes having metastatic 
cancer cells.”
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The fluorescent dye enters cancer cells through endocytosis. 
The dye will not enter healthy cells, which do not have the 
necessary receptor, thus creating a clear visualization of the 
cancer cells present among healthy cells.
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